Senxiang Yan

1.6k total citations
89 papers, 1.0k citations indexed

About

Senxiang Yan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Senxiang Yan has authored 89 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 21 papers in Oncology. Recurrent topics in Senxiang Yan's work include Advanced Radiotherapy Techniques (14 papers), Head and Neck Cancer Studies (10 papers) and RNA modifications and cancer (8 papers). Senxiang Yan is often cited by papers focused on Advanced Radiotherapy Techniques (14 papers), Head and Neck Cancer Studies (10 papers) and RNA modifications and cancer (8 papers). Senxiang Yan collaborates with scholars based in China, Hong Kong and United States. Senxiang Yan's co-authors include Yì Wáng, Lingyun Wu, Feng Zhao, Shui‐Hong Zhou, Zhongjie Lu, Xin-Biao Liao, Meiqin Chen, Xinke Li, Hao Yu and Jun Fan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Senxiang Yan

82 papers receiving 1.0k citations

Peers

Senxiang Yan
Jingao Li China
Hong Zhu China
Robert W. Mutter United States
Hong Ge China
Senxiang Yan
Citations per year, relative to Senxiang Yan Senxiang Yan (= 1×) peers Maobin Meng

Countries citing papers authored by Senxiang Yan

Since Specialization
Citations

This map shows the geographic impact of Senxiang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senxiang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senxiang Yan more than expected).

Fields of papers citing papers by Senxiang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Senxiang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senxiang Yan. The network helps show where Senxiang Yan may publish in the future.

Co-authorship network of co-authors of Senxiang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Senxiang Yan. A scholar is included among the top collaborators of Senxiang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Senxiang Yan. Senxiang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Senxiang, Yu Wang, Siyu Fu, et al.. (2025). Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine inhibitors of hematopoietic progenitor kinase 1. Bioorganic & Medicinal Chemistry Letters. 123. 130242–130242.
2.
Sun, Xin, Yuan‐Hua Chen, Zihan Sun, et al.. (2025). Optimizing fractionation schedules for de-escalation radiotherapy in head and neck cancers using deep reinforcement learning. Radiotherapy and Oncology. 207. 110833–110833.
3.
Ye, Xianghua, Xinke Li, Fang Wang, et al.. (2024). Dynamic change of gut microbiota in head and neck concurrent chemoradiotherapy patients and its potential value in the prediction of acute oral mucositis grade as well as quality of life. Clinical & Translational Oncology. 26(12). 3191–3201. 1 indexed citations
4.
Hu, Jing, et al.. (2024). COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway. Annals of Surgical Oncology. 31(5). 3502–3512. 3 indexed citations
5.
Zhou, Ziyang, et al.. (2023). Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer. Oxidative Medicine and Cellular Longevity. 2023. 1–14. 4 indexed citations
6.
Meng, Xue, Jun Wang, Xiao‐Yuan Wu, et al.. (2023). Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial. British Journal of Cancer. 129(11). 1787–1792. 12 indexed citations
7.
Wang, Pei, Jia Ge, Dandan Zheng, et al.. (2023). Anatomy-Guided Deep Learning Model for Accurate and Robust Gross Tumor Volume Segmentation in Lung Cancer Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). e71–e71. 1 indexed citations
9.
Yu, Hao, Cheng Wang, Lingyun Wu, et al.. (2023). A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging. Frontiers in Oncology. 12. 1077900–1077900. 5 indexed citations
10.
Yan, Senxiang, et al.. (2022). MsVRL: Self-Supervised Multiscale Visual Representation Learning via Cross-Level Consistency for Medical Image Segmentation. IEEE Transactions on Medical Imaging. 42(1). 91–102. 16 indexed citations
11.
Wang, Cheng, Lingyun Wu, Hao Yu, et al.. (2022). A powerful antitumor “trident”: the combination of radio-, immuno- and anti-angiogenesis therapy based on mesoporous silica single coated gold nanoparticles. Journal of Materials Chemistry B. 11(4). 879–889. 6 indexed citations
12.
Wang, Cheng, Lingyun Wu, Jiaqi Xu, et al.. (2021). An injectable double-crosslinking iodinated composite hydrogel as a potential radioprotective spacer with durable imaging function. Journal of Materials Chemistry B. 9(15). 3346–3356. 9 indexed citations
13.
Chen, Ying, Xue Jiang, Xinke Li, et al.. (2021). The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma. Annals of Translational Medicine. 9(16). 1346–1346. 11 indexed citations
14.
Wu, Lingyun, et al.. (2020). Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(5). 1368–1379. 23 indexed citations
15.
Wu, Lingyun, Xin Yin, Mengmeng Tang, et al.. (2019). The Therapeutic Potential of Adipose Tissue-Derived Mesenchymal Stem Cells to Enhance Radiotherapy Effects on Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 7. 267–267. 20 indexed citations
16.
Liu, Kaitai, et al.. (2018). Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer. Cancer Management and Research. Volume 10. 2259–2268. 5 indexed citations
17.
Zhao, Feng, Xinke Li, Fang Wang, et al.. (2017). Herpes simplex encephalitis during radiation therapy in a patient with nasopharyngeal carcinoma. Translational Cancer Research. 6(6). 1149–1155. 2 indexed citations
18.
Yan, Senxiang, et al.. (2014). Postoperative Radiotherapy for Glioma: Improved Delineation of the Clinical Target Volume Using the Geodesic Distance Calculation. PLoS ONE. 9(6). e98616–e98616. 1 indexed citations
19.
Ye, Xianghua, Liang Song, Ling Peng, et al.. (2014). Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis. Molecular Genetics and Genomics. 290(2). 545–558. 16 indexed citations
20.
Yan, Senxiang, et al.. (1996). Acid-Induced Folding of Yeast Alcohol Dehydrogenase under Low pH Conditions. The Journal of Biochemistry. 119(4). 674–679. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026